selected publications
-
academic article
- Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis.. Journal of neuroimmunology. 214:67-77. 2009
- Aqueous suspension polymerization of isobutene initiated by 1,2-C6F4[B(C6F5)2]2.. Journal of the American Chemical Society. 127:46-47. 2005
- Isobutene polymerization using a chelating diborane co-initiator.. Journal of the American Chemical Society. 125:14686-14687. 2003
- Arabidopsis genes essential for seedling viability: isolation of insertional mutants and molecular cloning.. Genetics. 159:1765-1778. 2001
- Regulated expression of human filaggrin in keratinocytes results in cytoskeletal disruption, loss of cell-cell adhesion, and cell cycle arrest.. Experimental cell research. 270:199-213. 2001
- Regulation of human profilaggrin promoter activity in cultured epithelial cells by retinoic acid and glucocorticoids.. Journal of dermatological science. 27:192-205. 2001
- Proprotein convertase expression and localization in epidermis: evidence for multiple roles and substrates.. Experimental dermatology. 10:193-203. 2001
- Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris.. The Journal of investigative dermatology. 115:1072-1081. 2000
- Inducible expression of filaggrin increases keratinocyte susceptibility to apoptotic cell death.. Cell death and differentiation. 7:566-573. 2000
- E-cadherin in the developing mouse gonad.. Anatomy and embryology. 200:91-102. 1999
- Evidence for specific proteolytic cleavage of the N-terminal domain of human profilaggrin during epidermal differentiation.. The Journal of investigative dermatology. 108:170-178. 1997
- Transient expression of epidermal filaggrin in cultured cells causes collapse of intermediate filament networks with alteration of cell shape and nuclear integrity.. The Journal of investigative dermatology. 108:179-187. 1997
- Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.. Drugs. 32:481-508. 1986